News
Archive
Antevia Networks deploys 5G private network at Bath Rugby stadium
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
Paragraf produces first 6-inch graphene wafer at new Huntingdon facility
Long Wall announces Cyclops: the mass-producible interceptor
Novadip recruits first pediatric patients in pivotal phase 3 trial of tissue regenerative treatment NVD003 in congenital pseudoarthrosis of the tibia
Ventyx provides clinical and corporate updates
Back To News